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Background: As common complications of coronary artery bypass grafting 
(CABG), low vascular resistance and hypotension could be life threatening. 
The aim of present study was to investigate the effect of low-dose vasopressin 
on hemodynamics in CABG patients.  
Materials and Methods: In this randomized double-blinded clinical trial, 80 
patients undergoing selective CABG were randomly divided into two equal 
case and control groups (n=40). Case group was received vasopressin 0.03 
IU/min 30 minutes before the end of cardio-pulmonary bypass (CPB) until 
one hour after that. Control group was received normal saline in the same 
manner. Dopamine requirement, ICU stay, heart rate (HR), mean arterial 
blood pressure (MAP), central venues pressure (CVP) and atrial blood acidity 
(pH) were recorded and compared between groups in 5 phases 
(0,30,60,90,120 min) after separation of CPB.  
Results: There was no significant difference between two groups in number 
of patients with severe hypotension (11 vs. 12 patients in case and control 
group respectively). CVP was corrected and then dopamine administration 
was compared in both groups. In vasopressin and the placebo group, 3 vs. 
11 patients need to dopamine administration immediately after separation 
from CPB (p= 0.018) and 4 vs. 12 patients later in ICU (p=0.024), 
respectively. The mean needed dose of dopamine in vasopressin and 
placebo group immediately after separation from CPB were 7.63±3.42 vs. 
9.21±2.08 µg/kg/min (p=0.031) and later in ICU were 7.42±2.02 vs. 
8.66±4.08 µg/kg/min (p=0.045) respectively, which was significantly lower 
in vasopressin group in comparison with the placebo group.  
Conclusion: Based on our results, low-dose vasopressin administration 
significantly reduced the mean needed dose of required dopamine, 24 hours 
urinary output, Duration of mechanical ventilation and patient’s heart rate.  
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Introduction 
Postoperative vasoplegic syndrome (PVS) is 
one of the important complications of coronary artery 
bypass grafting (CABG) which is characterized by 
hemodynamic instability due to low systemic vascular 
resistance, normal or elevated cardiac output and poor 
response to volume administration (1). The incidence 
of such situation was reported about 8-26% in on-
pump surgeries (2). Some different mechanisms have 
been associated with PVS, such as hypothermia and 
duration of cardiopulmonary bypass (CPB), total 
cardioplegic volume infused, preoperative 
medications, and systemic inflammatory response 
syndrome (SIRS) (3). 
An advanced form of PVS is a life-threatening 
condition which is resistant to conventional treatment, 
fluid administration, inotropes, and catecholamines 
(4). 
Comparable to septic shock, vasodilatory 
shock after cardiac surgery is characterized by poor 
response of vascular smooth muscles to circulating 
catecholamines (5). Recently the administration of 
low dose vasopressin has shown promising effect on 
improvement of left ventricular function (6), 
increasing cardiac output and coronary blood flow, 
which is effective in postoperative hypotension (7, 8). 
Yimin and collages have been reported better 
hemodynamic stability by vasopressin in CABG (9). 
Elgebaly and his collages have shown similar results 
too. They concluded that infusion of low-dose 
vasopressin for patients with mild to moderate left 
ventricular systolic dysfunction during separation 
from CPB is beneficial for the postoperative 
hemodynamic profiles, reduces the catecholamine 
doses required and improves left ventricular systolic 
function (10).  
Based on such reports, this study was 
conducted to investigate the effect of low dose 
vasopressin on the hemodynamics and inotrope 
requirement after on-pump CABG surgeries in 
patients that had mild to moderate LV systolic 
dysfunction. 
Methods 
In this randomized double-blinded clinical 
trial, 80 patients who were candidate for elective 
CABG, with ejection fraction (EF)=35-50% were 
enrolled in the study and received same anesthetic 
regimen and operated by the same surgical team. 
Patients were observed by transesophageal 
echocardiography (TEE) and EF was measured prior 
to and after cardio-pulmonary bypass (CBP). The 
protocol of the study was approved by Tehran 
University of Medical Sciences Ethics Committee and 
written informed consent forms were obtained from 
all patients. 
Patients with EF>50% or EF<35%, history of 
renal or liver failure, epilepsy, patients who need 
emergent surgery or valvular surgery, and any history 
of allergic reaction to vasopressin were excluded. 
The patients in this study were monitored with 
ECG, invasive blood pressure (IBP), SpO2, and 
cerebral oximetry after they entered the operating 
room. In all patients, premedication was administered 
1mg oral Lorazepam and 0.1mg/kg intramuscular 
morphine was administered 2 hours and one hour 
before surgery. Induction of anesthesia was 
performed with midazolam 0.05 mg/kg, etomidate 0.3 
mg/kg, atracurium 0.5 mg/kg, and fentanyl 5-10 
µg/kg. Then central venous catheters were placed 
after anesthesia induction. Maintenance of anesthesia 
was performed with: Midazolam 0.05 mg/kg/h, 
atracurium 5-10µg/kg/min, and fentanyl 5µg/kg/min. 
If needed we used low doses of propofol.  
The anesthesiologists, surgeons, nurses, and 
the statistician were blinded to the protocol. In 
operation room patients were randomly divided into 
two equal case and control groups (n=40). Case group 
was received vasopressin 0.03 IU/min. 30 minutes 
before the end of CPB until one hour after that. The 
control group was received normal saline in same 
manner. 
Using crystaloids, colloids, inotropes, 
vasoactive drugs and red blood cells, CVP, MAP, HR 
and HCT were kept in the target range. Our target in 
this study was MAP; 50-70mmHg, and Hematocrit 
(HCT); 20-30% during CPB. Also, after CPB we 
managed to keep MAP≥ 70 mmHg, CVP; 6-
12cmH2o; HR; 70-90 bpm and HCT≥27%. 
Demographic and clinical information of all 
patients were recorded. Operation time, CPB time, 24 
hours volume of blood loss and urinary output, the 
incidence of arrhythmia, dopamine requirement of 
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separation from CPB and in the ICU, mechanical 
ventilation duration and ICU stay were recorded and 
compared between groups. The heart rate (HR), mean 
arterial blood pressure (MAP), central venues 
pressure (CVP) and atrial blood acidity (pH) were 
recorded every 30 minutes after separation of CPB till 
120 minutes after that. 
All statistical analyses were performed with 
SPSS software 21 package and statistical significance 
was considered at p≤0.05. 
Results 
There was no significant difference between 
two groups in age, gender, weight, height, EF, 
hypertension, diabetes mellitus, CPB time, and blood 
loss volume. All patients were successfully separated 
from CPB in first attempt without any mortality. 
Postoperative urinary output during first 24 hours was 
significantly lower in vasopressin group (p=0.001). 
Moreover the blood loss in first 24 hours was 
insignificantly lower in vasopressin group in 
comparison to control group (p=0.214) (Table 1).  
CVP was corrected in vasopressin and placebo 
group and then dopamine administration was 
compared in both groups. In vasopressin and placebo 
group, 3 and 11 patients need to dopamine 
administration immediately after separation from 
CPB (p= 0.018; using Fisher’s Exact Test) and 4 and 
12 patients in ICU (p=0.024; using Fisher’s Exact 
Test) respectively. The mean needed dose of 
dopamine in vasopressin and placebo group 
immediately after separation from CPB were 
7.63±3.42 and 9.21±2.08 µg/kg/min (p=0.031) and in 
ICU were 7.42±2.02 and 8.66±4.08 µg/kg/min 
(p=0.045), respectively which were significantly 
lower in vasopressin group in comparison to placebo 
group. 
None of the patients have shown hypertensive 
crisis. Hemodynamic data of patients in both groups 
were reported in Table 2. 
Severe hypotension was considered the 
hemodynamic state characterized by MAP of less 
than 70 mmHg (11). There was no significant 
difference in the number of patients with severe 
hypotension (11 vs. 12 patients in case and control 
groups respectively). 
CVP was monitored as an index of preload. 
Metabolic acidosis was defined as pH<7.3, which was 
not reported in groups. There was no significant 
difference in CVP and PH between groups also (Table 
2). 
Despite similar CVP without significance 
difference between groups, heart rate in vasopressin 
group were significantly lower than control group in 
all five evaluations (p=0.000). 
The number of patients using ACE inhibitors 
and angiotensin receptor blocker (ARBS) were equal 
in both groups and there was no correlation between 
these medications and number of patients with severe 
hypotension in vasopressin and control group 
(p=0.934) or dose of dopamine needed for severe 
hypotension (p=0.975). 
The number of patients with arrhythmia in 
vasopressin and control group were 6 and 7 patients 
respectively (p=0.983) that did not differ between 
groups. 
Discussion 
Severe and unresponsive hypotension are an 
abruption in hemodynamic stability in the first hours 
after open heart surgery due to either the 
inflammatory mediators produced by CPB or 
preoperative medications such as ACE inhibitors, 
angiotensin receptor blocker, and so on (4, 12). In our 
study there were no difference in two preoperative 
affective variables, ejection fraction and there was no 
correlation between these medications and number of 
patients with severe hypotension in vasopressin and 
control group or the dose of dopamine needed for 
severe hypotension. Argenziano showed that both low 
EF and the use of ACE inhibitors were independent 
risk factors for postoperative vasodilatory shock and 
severe hypotension (12). 
As this study showed, prophylactic use of 
vasopressin did not increase MAP and prevent severe 
hypotension in comparison with the control group, 
this is opposite to Papadopoulos study that 
demonstrated low dose vasopressin can significantly 
reduce vasodilatory shock (4% vs. 20 % in 
vasopressin and control group respectively) (4). These 
different results may be due to different definition of 
postoperative vasodilatory shock and severe 
hypotension. 
Postoperative urinary output during the first 24 
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hours was significantly lower in vasopressin group. It 
can be due to the vasoconstrictive effect of 
vasopressin on renal arteries or its effect as 
antidiuretic hormone. Papadopoulos in his study 
concluded vasopressin administration was associated 
with a higher 24 hour diuresis (4). 
Duration of mechanical ventilation was 
significantly lower in vasopressin group too. It can be 
because of less dopamine administration, and more 
stability of MAP and HR in this group. 
Table 1: Demographic data, mean (SD), ratios and number (percentage) of patients. 
 






58.35 (8.23) 58.35 (7.84) 1.000 
Gender (M/F) 
27/13 25/15 0.407 
Weight (kg) 
69.11(11.82) 68.82(11.03) 0.908 
Height (cm) 166.80(7.20) 166.18(7.66) 0.708 
Ejection fraction (%) 
42.12(5.30) 44.21(7.75) 0.168 
Hypertension (Y/N) 
23/17 24/16 0.50 
Diabetes mellitus (Y/N) 13/27 14/26 0.50 
Angiotensin receptor blocker 7 11 0.607 
Angiotensin-converting-enzyme inhibitor 18 20 0.412 
Nitrates 34 36 0.369 
Cardiopulmonary bypass (min) 90.45(29.57) 79.92(29.91) 0.118 
24 hours Blood volume loss (ml) 505.00(293.28) 722.50(1057.56) 0.214 




Duration of mechanical ventilation (hour) 12.025(10.12) 15.97(6.74)
* 
0.043* 
Arrhythmia (Y/N) 6/34 7/33 0.983 




Table 2: Hemodynamic data of patients in both study group. 
 
group parameter 
At the end 
of CPB 
30 min after 
the end of 
CPB 
60 min after 
the end of 
CPB 
90 min after 




end of CPB 
Vasopressin 
group(n=40) 
HR (beat/min) 84.3 (10.1) 82.5 (9.4) 81.4 (10.3) 82 (9.5) 84.2 (10.7) 
MAP (mmHg) 67.3 (12.8) 75.7 (11.4) 77.3 (11.6) 74.8 (14.0) 74.1 (15.8) 
CVP (cm H2O) 8.2 (3.5) 7.7 (2.5) 8.7 (1.8) 8.4 (2.2) 9.4 (1.8) 
pH 7.44 (0.07) 7.42 (0.05) 7.44 (0.06) 7.43 (0.08) 7.38 (0.05) 
Placebo 
group(n=40) 
HR (beat/min) 91.1 (15.7) 92.9 (13.7) 94.1 (14.3) 94.3 (14.2) 94.7 (14.3) 
MAP (mmHg) 70.5 (12.3) 76.2 (11.6) 74.2 (12.14) 78.8 (11.8) 84.2 (15.7) 
CVP (cm H2O) 7.7 (3.7) 7.4 (3.3) 8.4 (2.4) 9.1 (2.6) 9.1 (2.4) 
pH 7.42 (0.08) 7.39 (0.05) 7.40 (0.06) 7.40 (0.06) 7.40 (0.06) 
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There was not any sever complication and 
mortality in our study. Patel B, in his study, used low 
dose vasopressin (0.03 IU/min) and the study that was 
done by Suojaranta-Ylinen, used vasopressin in 
combination with norepinephrine and both study 
showed no increased mortality (13, 14). Our result is 
similar to both of these studies. 
There is not enough knowledge about 
vasopressin effective and appropriate dose. Some 
investigators showed that vasopressin in dose of 2-6 
U/h is effective in vasodilatory shock treatment (11, 
15) but the appropriate dose for preventing the severe 
hypotension is not clear. In Papadopoulos G study 
showed 12.4±1.3 units of vasopressin may prevent 
vasodilatory shock and cause significant increase in 
MAP (4) which is different from our results. 
It seems more investigations are needed to 
evaluate vasopressin effect on hemodynamic status 
after open heart surgery and CABG with different 
dosage. 
Because of our limitation we could not 
measure cardiac output so we just measured MAP as 
only criteria for severe hypotension definition which 
is our strong study limitation. We were measured EF 
using TEE prior to and after CPB as an index of 
cardiac function and CVP as a preload indicator. 
Conclusion 
Based on our results, administration low-dose 
vasopressin (0.03 IU/min) significantly reduced the 
mean needed dose of required dopamine and patient’s 
heart rate (30 minutes before the end of CPB until one 
hour after that). The number of patients with severe 
hypotension (MAP<70mmHg) was not different 
between groups. Vasopressin administration had no 
significant effect on ICU stay duration, mean arterial 
blood pressure, CVP, and arterial pH. 
 
 
Figure 1. Mechanism of  action of Vasopressin 
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